Theravance Biopharma, Inc. (TBPH)
17.01
-0.01
(-0.06%)
USD |
NASDAQ |
Sep 11, 16:00
17.02
+0.01
(+0.06%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 882.67M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 24.16% |
| Valuation | |
| PE Ratio | 16.85 |
| PE Ratio (Forward) | |
| PS Ratio | 8.476 |
| Price to Book Value | 3.047 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2463 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 84.09% |
Profile
| Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of human therapeutics. It operates through the following geographical segments: US and Europe. The company was founded in July 2013 and is headquartered in South San Francisco, CA. |
| URL | http://www.theravance.com |
| Investor Relations URL | https://investor.theravance.com/ |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 10, 2026 (est.) |
| Last Earnings Release | Aug. 10, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of human therapeutics. It operates through the following geographical segments: US and Europe. The company was founded in July 2013 and is headquartered in South San Francisco, CA. |
| URL | http://www.theravance.com |
| Investor Relations URL | https://investor.theravance.com/ |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 10, 2026 (est.) |
| Last Earnings Release | Aug. 10, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |